Patent Application
Utility
App. No. 17/818,653
· Confirmation No. 6514
COMPOSITION CONTAINING SULFOALKYL ETHER CYCLODEXTRIN AND LATANOPROST
Applicant:
CyDex Pharmaceuticals, Inc.
Abandoned -- Failure to Respond to an Office Action
View Publication ↗
|
⬇ PDF
|
Code | Description | Pages | ||
|---|---|---|---|---|---|
| 2024-01-04 | ABN |
Abandonment | 2 | View | |
| 2023-06-23 | CTNF |
Non-Final Rejection | 9 | View | |
| 2023-06-23 | 892 |
List of references cited by examiner | 1 | View | |
| 2023-06-23 | SRFW |
Search information including classification, databases and other search related notes | 1 | View | |
| 2023-06-23 | BIB |
Bibliographic Data Sheet | 1 | View | |
| 2023-06-23 | SRNT |
Examiner's search strategy and results | 10 | View | |
| 2022-12-08 | NTC.PUB |
Notice of Publication | 1 | View | |
| 2022-11-29 | C.AD.PC |
Change of Address via Patent Center | 1 | View | |
| 2022-08-30 | APP.FILE.REC |
Filing Receipt | 3 | View | |
| 2022-08-30 | WFEE |
Fee Worksheet (SB06) | 1 | View | |
| 2022-08-23 | LET. |
Miscellaneous Incoming Letter | 1 | View | |
| 2022-08-23 | N417 |
Electronic Filing System Acknowledgment Receipt | 2 | View | |
| 2022-08-12 | A.PE |
Preliminary Amendment | 1 | View | |
| 2022-08-12 | SPEC |
Specification | 1 | View | |
| 2022-08-12 | CLM |
Claims | 2 | View | |
| 2022-08-12 | REM |
Applicant Arguments/Remarks Made in an Amendment | 2 | View | |
| 2022-08-12 | N417 |
Electronic Filing System Acknowledgment Receipt | 2 | View | |
| 2022-08-12 | A.PE |
Preliminary Amendment | — | View | |
| 2022-08-09 | PA.. |
Power of Attorney | 2 | View | |
| 2022-08-09 | DRW |
Drawings-only black and white line drawings | 3 | View | |
| 2022-08-09 | OATH |
Oath or Declaration filed | 2 | View | |
| 2022-08-09 | N417 |
Electronic Filing System Acknowledgment Receipt | 3 | View | |
| 2022-08-09 | ADS |
Application Data Sheet | 9 | View | |
| 2022-08-09 | N417.PYMT |
Electronic Fee Payment | 2 | View | |
| 2022-08-09 | SPEC |
Specification | 34 | View | |
| 2022-08-09 | CLM |
Claims | 3 | View | |
| 2022-08-09 | ABST |
Abstract | 1 | View |
Inventors
Naomi Esaki
Lenexa, KS
James D. Pipkin
Lawrence, KS
Attorneys & Agents of Record
Classification
USPC
424/400
A61K31/557
A61P27/02
A61K9/0048
A61K31/74
A61K47/40
Prosecution
- Examiner
- BABSON, NICOLE PLOURDE
- Art Unit
- 1619
- Customer No.
- 190734
- Docket No.
- LIGAN4.019C2
- Confirmation No.
- 6514
Publication
- Pub. No.
- US20220387444A1
- Pub. Date
- 2022-12-08
Parent
is a Continuation of
→
App. 16/672,170
· US 11,433,082
Filed 2019-11-01
· Patented Case
Parent
is a Continuation of
→
App. 13/128,319
· US 10,463,677
Filed 2011-09-26
· Patented Case
Parent
PCT
is a National Stage Entry of
→
PCT/US2008/082730
Filed 2008-11-07
· Abandoned -- Failure to Respond to an Office Action
from
CYDEX PHARMACEUTICALS, INC.,
LIGAND PHARMACEUTICALS INCORPORATED,
METABASIS THERAPEUTICS, INC.,
PFENEX INC.
SECURITY INTEREST
Recorded 2023-10-18
ASSIGNMENT OF ASSIGNOR'S INTEREST
Recorded 2022-10-05
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this application's details
Quick Facts
- App. No.
- 17/818,653
- Filed
- 2022-08-09
- Pub. No.
- US20220387444A1
- Examiner
- BABSON, NICOLE PLOURDE
- Art Unit
- 1619
External Links